{'fraction_non_alphanumeric': 0.028795811518324606, 'fraction_numerical': 0.0, 'mean_word_length': 4.984375, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Keeping science on top in drug evaluation.

The approval, prescribing, and safety surveillance of prescription drugs involve a complicated mix of science, regulatory law, clinical judgment, business, and politics. Dr. Jerry Avorn writes that though the quiet voice of science may often be no match for powerful vested interests or ideology, some encouraging signs may be in the air.